Clinical scientists in Ophthalmopthy knows P1. Even worse actually, Anti-Complement Therapies. https://t.co/9KCwxAl4GD P2. intravitreal injections spanning over several years. 1 your done!👍☑️ Now someone will do everything to bury it! $OCGN https://

@AnnKumfer We discussed eculizumab and its use in atypical HUS in our review article related to anti-complement therapy (now >10 years old!): https://t.co/r8qDVD9iYf